| Dr Timothy James Fehlauer, OD | |
|
116 S Main St, Sheridan, WY 82801-4224 | |
| (307) 675-2020 | |
| Not Available |
| Full Name | Dr Timothy James Fehlauer |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 21 Years |
| Location | 116 S Main St, Sheridan, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316983950 | NPI | - | NPPES |
| 119284100 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 286T (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sheridan Eye Care Center Inc | 4789573106 | 3 |
News Archive
Although the value of vaccines for COVID-19 may seem obvious, government action and investment in vaccines have not been commensurate with the enormous scale of benefits they offer, argue Juan Camilo Castillo and colleagues in this Policy Forum.
Can environmental toxins disrupt circadian rhythms - the biological "clock" whose disturbance is linked to chronic inflammation and a host of human disorders? Research showing a link between circadian disruption and plankton that have adapted to road salt pollution puts the question squarely on the table.
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
While exercise therapy for heart failure (HF) patients with low heart function has been shown to be an effective prognostic tool, the level and format of exercise that yields optimal effects is still unclear.
› Verified 7 days ago
| Provider Name | Sheridan Eye Care Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720004351 PECOS PAC ID: 4789573106 Enrollment ID: O20040313000166 |
News Archive
Although the value of vaccines for COVID-19 may seem obvious, government action and investment in vaccines have not been commensurate with the enormous scale of benefits they offer, argue Juan Camilo Castillo and colleagues in this Policy Forum.
Can environmental toxins disrupt circadian rhythms - the biological "clock" whose disturbance is linked to chronic inflammation and a host of human disorders? Research showing a link between circadian disruption and plankton that have adapted to road salt pollution puts the question squarely on the table.
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
While exercise therapy for heart failure (HF) patients with low heart function has been shown to be an effective prognostic tool, the level and format of exercise that yields optimal effects is still unclear.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy James Fehlauer, OD 116 S Main St, Sheridan, WY 82801-4224 Ph: (307) 675-2020 | Dr Timothy James Fehlauer, OD 116 S Main St, Sheridan, WY 82801-4224 Ph: (307) 675-2020 |
News Archive
Although the value of vaccines for COVID-19 may seem obvious, government action and investment in vaccines have not been commensurate with the enormous scale of benefits they offer, argue Juan Camilo Castillo and colleagues in this Policy Forum.
Can environmental toxins disrupt circadian rhythms - the biological "clock" whose disturbance is linked to chronic inflammation and a host of human disorders? Research showing a link between circadian disruption and plankton that have adapted to road salt pollution puts the question squarely on the table.
Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL).
While exercise therapy for heart failure (HF) patients with low heart function has been shown to be an effective prognostic tool, the level and format of exercise that yields optimal effects is still unclear.
› Verified 7 days ago
Dr. Jill Miller, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 116 S Main St, Sheridan, WY 82801 Phone: 307-675-2020 | |
Dr. Matthew E Groshart, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 25 E Grinnell Plz, Sheridan, WY 82801 Phone: 307-674-7611 Fax: 307-672-7777 | |
Dr. Brandi N. Bilyeu, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1033 Coffeen Av, Sheridan, WY 82801 Phone: 307-674-0444 Fax: 307-673-0860 | |
Eye Care Of The Big Horns Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1033 Coffeen Ave., Sheridan, WY 82801 Phone: 307-674-0444 Fax: 307-673-0860 | |
Dr. Kathryn S. Dehn, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1033 Coffeen Avenue, Sheridan, WY 82801 Phone: 307-674-0444 Fax: 307-673-0860 | |
Dr. Joseph V Katschke, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1450 Sugarland Dr, Sheridan, WY 82801 Phone: 307-673-5177 Fax: 307-673-5170 |